Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.54
+0.12 (2.12%)
At close: Feb 13, 2026, 4:00 PM EST
5.68
+0.14 (2.62%)
After-hours: Feb 13, 2026, 4:21 PM EST
Cadrenal Therapeutics Employees
Cadrenal Therapeutics had 4 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,596,410
Market Cap
12.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 1 | 33.33% |
| Dec 31, 2022 | 3 | - | - |
| Sep 30, 2022 | 1 | - | - |
| Jun 30, 2022 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 28 |
| BioCardia | 20 |
| Moleculin Biotech | 17 |
| Quantum BioPharma | 17 |
| NewcelX | 15 |
| Cocrystal Pharma | 11 |
| Cellectar Biosciences | 11 |
| Allarity Therapeutics | 7 |
CVKD News
- 4 weeks ago - Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibitor - GlobeNewsWire
- 6 weeks ago - Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System - Accesswire
- 6 weeks ago - Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On - Accesswire
- 2 months ago - Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026 - GlobeNewsWire
- 2 months ago - Cadrenal's Quiet Expansion Play Is Starting to Get Loud - Accesswire
- 2 months ago - Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market - Accesswire
- 2 months ago - Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) - GlobeNewsWire
- 2 months ago - Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors - GlobeNewsWire